Yeung Gary Kahing — SEC Form 4 filings

SEC reporting owner CIK 2042700. 3 Form 4 filings on record with FilingPulse; latest filed 2024-12-13.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2024-11-14 to 2024-12-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
CERO THERAPEUTICS HOLDINGS, INC. (CERO)10% owner37 legs · 12,865,614 sh · $1,108,826

Form 4 filings — Yeung Gary Kahing

FiledFormIssuerReported transactionsSource
2024-12-134CERO THERAPEUTICS HOLDINGS, INC. (CERO)
jointly with YK Bioventures Opportunities GP I, LLC, YK Bioventures Opportunities Fund I, L.P., Kossar Mitchell William
Sale (S): 1,343,801 @ $0.08 · Sale (S): 1,614,541 @ $0.07 · Sale (S): 2,998,908 @ $0.06EDGAR
2024-12-104CERO THERAPEUTICS HOLDINGS, INC. (CERO)
jointly with YK Bioventures Opportunities GP I, LLC, YK Bioventures Opportunities Fund I, L.P., Kossar Mitchell William
Sale (S): 1,236,874 @ $0.12 · Sale (S): 850,543 @ $0.11 · Sale (S): 1,570,947 @ $0.09EDGAR
2024-11-144CERO THERAPEUTICS HOLDINGS, INC. (CERO)
jointly with YK Bioventures Opportunities GP I, LLC, YK Bioventures Opportunities Fund I, L.P., Kossar Mitchell William
Sale (S): 3,250,000 @ $0.10EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2042700 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →